[16] and further confirms the carcinogenic safety of tirzepatide in patients with obesity who do not have diabetes
By Bob Berendsen March 5, 2024 Peripheral nerve stimulation (PNS) is a minimally invasive procedure that involves implanting a small device near the affected nerve to deliver electrical pulses that block pain signals
The Lancet, 368 (9548), 1696-1705
To get TRICARE to cover Wegovy or Zepbound for weight loss, you must meet these criteria: Clinical Requirements BMI of 30 or higher, OR BMI of 27 or higher with at least one weight-related condition (diabetes, hypertension, dyslipidemia, sleep apnea) Documentation Requirements Prescription from a TRICARE-authorized network provider Prior authorization form completed by your provider Evidence of previous weight loss attempts (typically diet and exercise for at least 6 months) Commitment to continue healthy lifestyle habits while on medication Initial approval period: 6 months
There's a stigma around obesity that its due to sloth and gluttony and thats just not true for most people who are obese
Antagonism between neuropeptides and monoamines in a distributed circuit for pathogen avoidance